Human	O
immunodeficiency	O
virus	O
type	O
1	O
Nef	O
protein	O
down-regulates	O
transcription	B-protein
factors	I-protein
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
in	O
vitro	O
after	O
T-cell	O
receptor	O
stimulation	O
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
negative	B-protein
factor	I-protein
(	O
Nef	B-protein
)	O
has	O
been	O
shown	O
to	O
down-regulate	O
the	O
transcription	B-protein
factors	I-protein
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
in	O
vitro	O
.	O

To	O
define	O
the	O
mechanism	O
of	O
action	O
of	O
the	O
Nef	B-protein
protein	O
,	O
the	O
signal	O
transduction	O
pathways	O
which	O
may	O
be	O
affected	O
in	O
T	B-cell_type
cells	I-cell_type
by	O
constitutive	O
expression	O
of	O
the	O
nef	O
gene	O
were	O
examined	O
.	O

Stimulation	O
of	O
T	B-cell_type
cells	I-cell_type
with	O
tumor	O
necrosis	O
factor	O
,	O
interleukin-1	O
,	O
or	O
lipopolysaccharide	O
resulted	O
in	O
the	O
recruitment	O
of	O
transcriptional	O
factors	O
to	O
a	O
similar	O
level	O
whether	O
or	O
not	O
the	O
cells	O
expressed	O
the	O
nef	O
gene	O
.	O

On	O
the	O
other	O
hand	O
,	O
stimulation	O
of	O
T	B-cell_type
cells	I-cell_type
by	O
mitogens	O
or	O
antibodies	O
to	O
the	O
T-cell	O
receptor	O
(	O
TCR	O
)	O
-	O
CD3	B-protein
complex	O
resulted	O
in	O
the	O
down-regulation	O
of	O
transcriptional	O
factors	O
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
in	O
cells	O
expressing	O
the	O
nef	O
gene	O
compared	O
with	O
cells	O
not	O
expressing	O
the	O
nef	O
gene	O
.	O

Because	O
the	O
Nef	B-protein
protein	O
does	O
not	O
affect	O
the	O
surface	O
expression	O
of	O
the	O
CD3	B-protein
-TCR	O
complex	O
,	O
we	O
conclude	O
that	O
the	O
Nef	B-protein
protein	O
down-regulates	O
the	O
transcriptional	O
factors	O
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
in	O
T	B-cell_type
cells	I-cell_type
in	O
vitro	O
through	O
an	O
effect	O
on	O
the	O
TCR-dependent	O
signal	O
transduction	O
pathway	O
.	O

Journat	NULL
or	NULL
ViroLOGy	NULL
,	NULL
May	NULL
1994	NULL
,	NULL
p.	NULL
3243-3249	NULL
0022-538X/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Nef	NULL
Protein	NULL
Down-Regulates	NULL
Transcription	NULL
Factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
In	NULL
Vitro	NULL
after	NULL
T-Cell	NULL
Receptor	NULL
Stimulation	NULL
JUAN	NULL
C.	NULL
BANDRES	NULL
anp	NULL
LEE	NULL
RATNER*	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Molecular	NULL
Microbiology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
Received	NULL
12	NULL
November	NULL
1993/Accepted	NULL
16	NULL
February	NULL
1994	NULL
Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
negative	NULL
factor	NULL
(	NULL
Nef	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down-regulate	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
vitro	NULL
.	NULL

To	NULL
define	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
Nef	NULL
protein	NULL
,	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
which	NULL
may	NULL
be	NULL
affected	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
were	NULL
examined	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
interleukin-1	NULL
,	NULL
or	NULL
lipopolysaccharide	NULL
resulted	NULL
in	NULL
the	NULL
recruitment	NULL
of	NULL
transcriptional	NULL
factors	NULL
to	NULL
a	NULL
similar	NULL
level	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
cells	NULL
expressed	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
mitogens	NULL
or	NULL
antibodies	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-CD3	NULL
complex	NULL
resulted	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
transcriptional	NULL
factors	NULL
NF-B	NULL
and	NULL
AP-1	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
nef	NULL
gene	NULL
compared	NULL
with	NULL
cells	NULL
not	NULL
expressing	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

Because	NULL
the	NULL
Nef	NULL
protein	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD3-TCR	NULL
complex	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
Nef	NULL
protein	NULL
down-regulates	NULL
the	NULL
transcriptional	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
through	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
TCR-dependent	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
negative	NULL
factor	NULL
(	NULL
Nef	NULL
)	NULL
is	NULL
dispensable	NULL
for	NULL
virus	NULL
replication	NULL
in	NULL
vitro	NULL
(	NULL
10	NULL
,	NULL
44	NULL
)	NULL
but	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
pathogenicity	NULL
of	NULL
the	NULL
closely	NULL
related	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
6	NULL
,	NULL
22	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
HIV-1	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
Nef	NULL
proteins	NULL
affect	NULL
virus	NULL
replication	NULL
in	NULL
vitro	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
and	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
related	NULL
to	NULL
down-regulation	NULL
of	NULL
transcriptional	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

These	NULL
transcriptional	NULL
factors	NULL
normally	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
proliferation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
HIV-1	NULL
promoter	NULL
possesses	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
which	NULL
allow	NULL
the	NULL
virus	NULL
to	NULL
subvert	NULL
the	NULL
normal	NULL
activity	NULL
of	NULL
these	NULL
factors	NULL
to	NULL
enhance	NULL
its	NULL
own	NULL
replication	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
affects	NULL
signal	NULL
transduction	NULL
is	NULL
unknown	NULL
.	NULL

Although	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
also	NULL
down-regulates	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD4	NULL
(	NULL
13	NULL
)	NULL
,	NULL
the	NULL
mechanism	NULL
for	NULL
this	NULL
effect	NULL
is	NULL
also	NULL
unknown	NULL
.	NULL

However	NULL
,	NULL
this	NULL
function	NULL
requires	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Because	NULL
Nef	NULL
protein	NULL
localizes	NULL
preferentially	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
membranes	NULL
,	NULL
and	NULL
cytoskeleton	NULL
(	NULL
11	NULL
,	NULL
32	NULL
)	NULL
,	NULL
its	NULL
effects	NULL
on	NULL
nuclear	NULL
factors	NULL
must	NULL
be	NULL
mediated	NULL
by	NULL
a	NULL
physical	NULL
interaction	NULL
or	NULL
enzymatic	NULL
regulation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
factors	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Several	NULL
pathways	NULL
of	NULL
signal	NULL
transduction	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
described	NULL
.	NULL

Antigenic	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-CD3-CD4	NULL
complex	NULL
results	NULL
in	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
completely	NULL
understood	NULL
,	NULL
but	NULL
it	NULL
may	NULL
involve	NULL
dissociation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
I-	NULL
«	NULL
B	NULL
as	NULL
a	NULL
result	NULL
of	NULL
phosphorylation	NULL
and/or	NULL
proteolysis	NULL
of	NULL
I-kB	NULL
(	NULL
3	NULL
,	NULL
8	NULL
,	NULL
14	NULL
,	NULL
19-21	NULL
,	NULL
28	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Alterna-tively	NULL
,	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
cytokines	NULL
and	NULL
other	NULL
surface	NULL
receptors	NULL
(	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
[	NULL
TNF	NULL
]	NULL
,	NULL
interleukin-1	NULL
[	NULL
IL-1	NULL
]	NULL
,	NULL
lipopolysaccharide	NULL
[	NULL
LPS	NULL
]	NULL
)	NULL
,	NULL
also	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
transcriptional	NULL
factors	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
35	NULL
,	NULL
36	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
signal	NULL
transduction	NULL
path	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
S.	NULL
Euclid	NULL
Ave.	NULL
,	NULL
Box	NULL
8125	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
314	NULL
)	NULL
362-8836	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
314	NULL
)	NULL
362-8826	NULL
.	NULL

3243	NULL
way	NULL
(	NULL
s	NULL
)	NULL
affected	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

We	NULL
found	NULL
that	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
through	NULL
pathways	NULL
originating	NULL
from	NULL
the	NULL
TNF	NULL
or	NULL
IL-1	NULL
receptors	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
Nef	NULL
protein	NULL
,	NULL
whereas	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
through	NULL
the	NULL
TCR-CD3-CD4	NULL
complex	NULL
resulted	NULL
in	NULL
down-regulation	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Nef	NULL
protein	NULL
compared	NULL
with	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
not	NULL
expressing	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
used	NULL
included	NULL
Jurkat	NULL
(	NULL
J25	NULL
)	NULL
human	NULL
T-cell	NULL
clone	NULL
133	NULL
,	NULL
which	NULL
stably	NULL
expresses	NULL
the	NULL
Nef	NULL
protein	NULL
derived	NULL
from	NULL
the	NULL
HIV-1	NULL
isolate	NULL
NL-43	NULL
,	NULL
and	NULL
its	NULL
parental	NULL
counterpart	NULL
,	NULL
clone	NULL
22F6	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
Nef	NULL
protein	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Confirmation	NULL
of	NULL
Nef	NULL
protein	NULL
production	NULL
was	NULL
performed	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
rabbit	NULL
anti-Nef	NULL
serum	NULL
and	NULL
Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
analysis	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
logarithmic	NULL
growth	NULL
phase	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
combinations	NULL
of	NULL
50	NULL
to	NULL
75	NULL
ng	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
per	NULL
ml	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

,	NULL
13	NULL
ug	NULL
of	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
per	NULL
ml	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
1,000	NULL
U	NULL
of	NULL
TNF	NULL
per	NULL
ml	NULL
(	NULL
Genentech	NULL
Inc.	NULL
,	NULL
San	NULL
Fran-cisco	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
15	NULL
ng	NULL
of	NULL
recombinant	NULL
human	NULL
IL-1	NULL
per	NULL
ml	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
D.	NULL
Chaplin	NULL
,	NULL
Washington	NULL
University	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

,	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
per	NULL
ml	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Antibody	NULL
cross-linking	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
sheep	NULL
anti-mouse	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
antibody	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
Calif.	NULL
)	NULL
diluted	NULL
1:100	NULL
in	NULL
0.1	NULL
mM	NULL
Tris	NULL
buffer	NULL
(	NULL
pH	NULL
9.5	NULL
)	NULL
was	NULL
immobilized	NULL
onto	NULL
plastic	NULL
microtiter	NULL
plates	NULL
by	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
three	NULL
times	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
monoclonal	NULL
antibody	NULL
to	NULL
CD3	NULL
per	NULL
ml	NULL
(	NULL
Leu-4	NULL
,	NULL
Becton	NULL
Dickinson	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
then	NULL
they	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
microtiter	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
.	NULL

The	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
isoquinol	NULL
methylpiperazine	NULL
(	NULL
H-7	NULL
)	NULL
3244	NULL
BANDRES	NULL
AND	NULL
RATNER	NULL
J	NULL
.	NULL

A	NULL
)	NULL
SP1	NULL
B	NULL
)	NULL
NFkB	NULL
C	NULL
)	NULL
AP-1	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
T	NULL
I	NULL
z	NULL
T	NULL
3	NULL
T	NULL
6.	NULL
o.	NULL
o.	NULL
o.	NULL
o.	NULL
c.	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
LL	NULL
t	NULL
LL	NULL
&	NULL
o-	NULL
(	NULL
G	NULL
L-	NULL
0	NULL
wo	NULL
@	NULL
L	NULL
@	NULL
2	NULL
-	NULL
a	NULL
2	NULL
z	NULL
an	NULL
-	NULL
2	NULL
2	NULL
a	NULL
2	NULL
2	NULL
L	NULL
<	NULL
2	NULL
a	NULL
2	NULL
2	NULL
q	NULL
2	NULL
>	NULL
-	NULL
ad	NULL
c.	NULL
0	NULL
i-	NULL
=d	NULL
o	NULL
.	NULL

1	NULL
o	NULL
UJ	NULL
o	NULL
D	NULL
-o	NULL
J	NULL
o	NULL
1	NULL
E-	NULL
-_	NULL
C.	NULL
1	NULL
E-	NULL
_	NULL
_J	NULL
o	NULL
.	NULL

D	NULL
tid	NULL
.s	NULL
-	NULL
b4nd	NULL
|	NULL
]	NULL
l	NULL
]	NULL
L	NULL
]	NULL
l	NULL
k	NULL
l	NULL
]	NULL
l	NULL
]	NULL
22F6	NULL
133	NULL
22F6	NULL
133	NULL
22F6	NULL
133	NULL
1	NULL
Po-	NULL
--	NULL
a	NULL
peg	NULL
r	NULL
m__	NULL
60	NULL
>	NULL
«	NULL
0	NULL
so	NULL
i-	NULL
X	NULL
i	NULL
in	NULL
so	NULL
5	NULL
al	NULL
z	NULL
9	NULL
in	NULL
40	NULL
3	NULL
Z	NULL
x	NULL
9	NULL
!	NULL

40	NULL
I	NULL
F	NULL
ma	NULL
+-	NULL
L	NULL
’	NULL
A—J	NULL
~	NULL
so	NULL
2	NULL
I	NULL
s	NULL
w	NULL
20	NULL
~	NULL
L	NULL
E	NULL
20	NULL
>	NULL
g	NULL
20	NULL
-	NULL
>	NULL
j	NULL
16	NULL
<	NULL
10	NULL
i	NULL
3	NULL
_	NULL
C	NULL
do	NULL
Fa	NULL
l	NULL
r	NULL
o	NULL
&	NULL
R	NULL
TNF	NULL
LPS	NULL
PP	NULL
-	NULL
e	NULL
i	NULL
0	NULL
PS	NULL
P/P	NULL
_-	NULL
TNF	NULL
LPS	NULL
P/P	NULL
TNF	NULL
LPS	NULL
P/P	NULL
--	NULL
TNF	NULL
LPS	NULL
P/P	NULL
-	NULL
TNF	NULL
LPS	NULL
P/P	NULL
_-	NULL
TNF	NULL
LPS	NULL
PIP	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
PHA	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
shows	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
SP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
AP-1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
22F6	NULL
is	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
133	NULL
is	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
line	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
saline	NULL
(	NULL
-	NULL
)	NULL
,	NULL
TNF	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
P/P	NULL
)	NULL
.	NULL

Retarded	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
shown	NULL
;	NULL
free	NULL
DNA	NULL
complexes	NULL
are	NULL
not	NULL
shown	NULL
but	NULL
were	NULL
equivalent	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
evaluated	NULL
by	NULL
laser	NULL
densitometry	NULL
.	NULL

A	NULL
)	NULL
USF	NULL
B	NULL
)	NULL
NFkB	NULL
C	NULL
)	NULL
AP-	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
$	NULL
<	NULL
f	NULL
s	NULL
:	NULL
o.	NULL
o.	NULL
o.	NULL
Q.	NULL
E	NULL
A	NULL
iss	NULL
m	NULL
»	NULL
a	NULL
Pi	NULL
v-	NULL
v-	NULL
<	NULL
<	NULL
I	NULL
*~	NULL
<	NULL
4	NULL
*~	NULL
<	NULL
*-	NULL
<	NULL
4	NULL
.	NULL

<	NULL
R	NULL
T	NULL
*	NULL
|	NULL
*	NULL
=	NULL
pS	NULL
20	NULL
4	NULL
Eo	NULL
.	NULL

=	NULL
E	NULL
204	NULL
Bo	NULL
u	NULL
,	NULL
=	NULL
E	NULL
2009	NULL
Eo	NULL
.	NULL

=	NULL
E	NULL
%	NULL
tas	NULL
woo	NULL
___	NULL
tao	NULL
tnt	NULL
t+	NULL
#	NULL
twas	NULL
L	NULL
___	NULL
___	NULL
]	NULL
l	NULL
__f	NULL
d	NULL
L	NULL
)	NULL
I	NULL
_	NULL
]	NULL
133	NULL
22F6	NULL
133	NULL
s2F6	NULL
133	NULL
22F6	NULL
g	NULL
.	NULL

m-	NULL
mks	NULL
azn	NULL
,	NULL
d	NULL
2000	NULL
e	NULL
t	NULL
ZU	NULL
t	NULL
a	NULL
>	NULL
20	NULL
i	NULL
n	NULL
al	NULL
az	NULL
z	NULL
E	NULL
Woos	NULL
wo	NULL
,	NULL
,	NULL
(	NULL
Q	NULL
E	NULL
L.	NULL
30	NULL
lke	NULL
Z	NULL
4	NULL
asl	NULL
d	NULL
w	NULL
16	NULL
W	NULL
o	NULL
~	NULL
2	NULL
Z	NULL
6+	NULL
m	NULL
10	NULL
i-	NULL
i-3	NULL
.	NULL

s	NULL
<	NULL
2	NULL
ala	NULL
fm	NULL
a	NULL
'*	NULL
8	NULL
.°	NULL
c	NULL
a	NULL
r	NULL
n	NULL
&	NULL
C	NULL
o	NULL
§	NULL
0	NULL
IL-4	NULL
0	NULL
PP	NULL
.	NULL

00	NULL
dL4	NULL
-	NULL
PP	NULL
<	NULL
0	NULL
dLA4	NULL
P/P	NULL
.	NULL

db	NULL
_	NULL
PIP	NULL
I4	NULL
BIP	NULL
O	NULL
0s	NULL
00	NULL
IEA	NULL
PIP	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
AP-	NULL
!	NULL

and	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
recombinant	NULL
human	NULL
IL-1	NULL
or	NULL
PMA	NULL
and	NULL
PHA	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
shows	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
USF	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
AP-1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
22F6	NULL
is	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
133	NULL
is	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
linc	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
IL-1	NULL
,	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
P/P	NULL
)	NULL
,	NULL
or	NULL
sterile	NULL
saline	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Retarded	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
shown	NULL
;	NULL
free	NULL
DNA	NULL
complexes	NULL
are	NULL
not	NULL
shown	NULL
but	NULL
were	NULL
equivalent	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
evaluated	NULL
by	NULL
laser	NULL
densitometry	NULL
.	NULL

Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
when	NULL
used	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
stimulants	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
wM	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
:	NULL
after	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesul-fonic	NULL
acid	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
-20	NULL
mM	NULL
KCl-1	NULL
mM	NULL
MgCl	NULL
,	NULL
-2	NULL
mM	NULL
dithio-threitol-17	NULL
%	NULL
glycerol	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
mM	NULL
sodium	NULL
fluoride	NULL
,	NULL
0.1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
B-glycerol-phosphate	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
2	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
,	NULL
Milwaukee	NULL
,	NULL
Wis.	NULL
)	NULL
,	NULL
20,000	NULL
to	NULL
40,000	NULL
cpm	NULL
of	NULL
end-labeled	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
equivalent	NULL
amount	NULL
of	NULL
labeled	NULL
probe	NULL
in	NULL
each	NULL
assay	NULL
for	NULL
a	NULL
given	NULL
experiment	NULL
,	NULL
with	NULL
or	NULL
without	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
in	NULL
DNA	NULL
binding	NULL
buffer	NULL
at	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
30	NULL
to	NULL
40	NULL
wl	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
at	NULL
30°C	NULL
for	NULL
25	NULL
min	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
.	NULL

For	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
the	NULL
following	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
used	NULL
:	NULL
NF-KB	NULL
,	NULL
ACAAGGGACTTTCCGCTGGGACTTTCCAGGGA	NULL
;	NULL
SP-1	NULL
,	NULL
CAGGGAGGCGTGGCCTGGGCGGGACTGGGGAG	NULL
TGGCGTCC	NULL
;	NULL
AP-1	NULL
,	NULL
CAGGGCCAGGAGTCAGATATCCA	NULL
CTGACCTTTGGATGGTGCT	NULL
;	NULL
and	NULL
USF	NULL
,	NULL
GCCGCTAGCA	NULL
TTTCATCACGTGGCCCGAGAGCTGC	NULL
.	NULL

All	NULL
DNA	NULL
probes	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
by	NULL
using	NULL
the	NULL
radiolabeled	NULL
probes	NULL
,	NULL
with	NULL
DNA-protein	NULL
complexes	NULL
being	NULL
separated	NULL
from	NULL
the	NULL
free	NULL
DNA	NULL
probe	NULL
by	NULL
electrophoresis	NULL
through	NULL
low-ionic-strength	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
run	NULL
at	NULL
200	NULL
V	NULL
with	NULL
Tris-borate-EDTA	NULL
(	NULL
3.7	NULL
g	NULL
of	NULL
Na	NULL
EDTA	NULL
,	NULL
54	NULL
g	NULL
of	NULL
Tris	NULL
,	NULL
and	NULL
27.5	NULL
g	NULL
of	NULL
boric	NULL
acid	NULL
per	NULL
liter	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
indicated	NULL
bands	NULL
for	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
determined	NULL
by	NULL
laser	NULL
densitometry	NULL
scanning	NULL
.	NULL

CAT	NULL
assay	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
with	NULL
samples	NULL
with	NULL
the	NULL
same	NULL
protein	NULL
concentration	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
Biorad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
parallel	NULL
with	NULL
previously	NULL
described	NULL
reporter	NULL
plasmids	NULL
Rous	NULL
sarcoma	NULL
virus-CAT	NULL
,	NULL
HIV-1-CAT	NULL
,	NULL
and	NULL
IL-2-CAT	NULL
(	NULL
1	NULL
,	NULL
41	NULL
)	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
values	NULL
obtained	NULL
in	NULL
parallel	NULL
from	NULL
the	NULL
noninducible	NULL
Rous	NULL
sarcoma	NULL
virus-CAT	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
fold	NULL
increases	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
acetylated	NULL
forms	NULL
compared	NULL
with	NULL
the	NULL
sum	NULL
of	NULL
that	NULL
of	NULL
the	NULL
acetylated	NULL
and	NULL
unacetylated	NULL
forms	NULL
.	NULL

RESULTS	NULL
To	NULL
evaluate	NULL
the	NULL
effects	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
activation	NULL
of	NULL
transcriptional	NULL
factors	NULL
through	NULL
protein	NULL
kinase	NULL
C-independent	NULL
mechanisms	NULL
,	NULL
Jurkat	NULL
cells	NULL
carrying	NULL
the	NULL
nef	NULL
gene	NULL
(	NULL
133	NULL
)	NULL
and	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
22F6	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
TNF	NULL
or	NULL
LPS	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
from	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
noninducible	NULL
factor	NULL
,	NULL
SP-1	NULL
,	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
protein	NULL
concentration	NULL
and	NULL
quality	NULL
of	NULL
the	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

TNF	NULL
or	NULL
LPS	NULL
induction	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Nef	NULL
protein	NULL
in	NULL
133	NULL
and	NULL
22F6	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
was	NULL
de-creased	NULL
,	NULL
by	NULL
6-fold	NULL
in	NULL
the	NULL
case	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
by	NULL
14-fold	NULL
in	NULL
the	NULL
case	NULL
of	NULL
AP-1	NULL
,	NULL
when	NULL
the	NULL
same	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
comparison	NULL
was	NULL
made	NULL
between	NULL
the	NULL
stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
that	NULL
with	NULL
PMA	NULL
or	NULL
TCR-SPECIFIC	NULL
EFFECTS	NULL
OF	NULL
HIV-1	NULL
Nef	NULL
3245	NULL
A	NULL
)	NULL
30	NULL
7	NULL
t	NULL
@	NULL
21	NULL
ud	NULL
3	NULL
U	NULL
<	NULL
2	NULL
10	NULL
[	NULL
e	NULL
]	NULL
th	NULL
o-IL-1	NULL
TNF	NULL
IL-1	NULL
TNF	NULL
L	NULL
po	NULL
J	NULL
22F6	NULL
133	NULL
B	NULL
)	NULL
40	NULL
7	NULL
3	NULL
30	NULL
{	NULL
<	NULL
u	NULL
te	NULL
U	NULL
€	NULL
#	NULL
7	NULL
o	NULL
«	NULL
l	NULL
[	NULL
e	NULL
]	NULL
*	NULL
_	NULL
19	NULL
4	NULL
0	NULL
IL-1	NULL
TNF	NULL
IL-1	NULL
TNF	NULL
L	NULL
T	NULL
J	NULL
22F6	NULL
133	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

CAT	NULL
assay	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
HIV	NULL
and	NULL
IL-2	NULL
transcription	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
22F6	NULL
is	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
133	NULL
is	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cell	NULL
line	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
HIV-1-long	NULL
terminal	NULL
repeat-CAT	NULL
(	NULL
A	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
recombinant	NULL
human	NULL
IL-1	NULL
or	NULL
TNF	NULL
.	NULL

Similar	NULL
experiments	NULL
with	NULL
IL-2-CAT	NULL
(	NULL
B	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
four	NULL
times	NULL
with	NULL
each	NULL
plasmid	NULL
,	NULL
a	NULL
mean	NULL
fold	NULL
induction	NULL
was	NULL
calculated	NULL
,	NULL
and	NULL
the	NULL
standard	NULL
deviation	NULL
of	NULL
the	NULL
mean	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
acetylation	NULL
of	NULL
HIV-1-CAT	NULL
were	NULL
4.6	NULL
+	NULL
0.7	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
4.4	NULL
+	NULL
0.4	NULL
(	NULL
TNF	NULL
)	NULL
for	NULL
22F6	NULL
cells	NULL
and	NULL
3.9	NULL
+	NULL
0.6	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
4.7	NULL
+	NULL
0.3	NULL
(	NULL
TNF	NULL
)	NULL
for	NULL
133	NULL
cells	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
acetylation	NULL
for	NULL
IL-2-CAT	NULL
were	NULL
14.9	NULL
+	NULL
0.9	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
17	NULL
+	NULL
0.7	NULL
(	NULL
TNF	NULL
)	NULL
for	NULL
22F6	NULL
cells	NULL
and	NULL
12.7	NULL
+	NULL
0.6	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
12.9	NULL
+	NULL
0.3	NULL
(	NULL
TNF	NULL
)	NULL
for	NULL
133	NULL
cells	NULL
.	NULL

PHA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Noninducible	NULL
transcription	NULL
factor	NULL
USF	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
activation	NULL
by	NULL
IL-1	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Nef	NULL
protein	NULL
in	NULL
133	NULL
and	NULL
22F6	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
or	NULL
PHA	NULL
resulted	NULL
in	NULL
down-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
5-fold	NULL
and	NULL
AP-1	NULL
by	NULL
15-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Nef	NULL
protein	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
correlated	NULL
with	NULL
transcriptional	NULL
activity	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DNA	NULL
plasmids	NULL
which	NULL
use	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
a	NULL
heterologous	NULL
gene	NULL
product	NULL
,	NULL
CAT	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF	NULL
or	NULL
IL-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
acetylation	NULL
between	NULL
the	NULL
cells	NULL
expressing	NULL
the	NULL
nef	NULL
gene	NULL
,	NULL
133	NULL
,	NULL
and	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
22F6	NULL
,	NULL
was	NULL
found	NULL
when	NULL
both	NULL
cell	NULL
lines	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
IL-1	NULL
or	NULL
TNF	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Because	NULL
Nef	NULL
protein	NULL
also	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
suppress	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
directed	NULL
by	NULL
the	NULL
IL-2-CAT	NULL
plasmid	NULL
(	NULL
26	NULL
)	NULL
,	NULL
both	NULL
133	NULL
cells	NULL
and	NULL
22F6	NULL
cells	NULL
containing	NULL
this	NULL
plasmid	NULL
were	NULL
stimulated	NULL
3246	NULL
BANDRES	NULL
AND	NULL
RATNER	NULL
J.	NULL
Viror	NULL
.	NULL

A	NULL
)	NULL
USF	NULL
B	NULL
)	NULL
NFKB	NULL
r	NULL
r	NULL
I~	NULL
:	NULL
&	NULL
A	NULL
x	NULL
x	NULL
s	NULL
a	NULL
a	NULL
3°	NULL
<	NULL
<	NULL
<	NULL
<	NULL
Co	NULL
m	NULL
§	NULL
<	NULL
1	NULL
:	NULL
:	NULL
<	NULL
ct	NULL
<	NULL
I	NULL
e	NULL
ind	NULL
T	NULL
I	NULL
TC	NULL
mnd	NULL
«	NULL
-	NULL
I-	NULL
a.	NULL
a.	NULL
o.	NULL
i	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
e	NULL
o	NULL
.	NULL

&	NULL
red	NULL
ree	NULL
a	NULL
<	NULL
<	NULL
js	NULL
w	NULL
pe	NULL
ws	NULL
s	NULL
=	NULL
S	NULL
=	NULL
S	NULL
n	NULL
=	NULL
n	NULL
2	NULL
=	NULL
I	NULL
=	NULL
``	NULL
=	NULL
-	NULL
Z	NULL
2	NULL
F	NULL
l	NULL
a	NULL
I	NULL
a	NULL
oa	NULL
IC	NULL
~	NULL
5	NULL
I	NULL
A	NULL
£	NULL
%	NULL
a.	NULL
a	NULL
IE	NULL
a	NULL
C	NULL
%	NULL
|	NULL
,	NULL
44	NULL
|	NULL
|	NULL
|	NULL
and	NULL
l	NULL
cll	NULL
22F6	NULL
133	NULL
s9r6	NULL
133	NULL
22F6	NULL
133	NULL
|	NULL
``	NULL
is	NULL
pennis	NULL
.	NULL

inc	NULL
omarion	NULL
-n	NULL
ree	NULL
ng	NULL
ener	NULL
neer	NULL
>	NULL
407	NULL
>	NULL
3	NULL
y-	NULL
A	NULL
«	NULL
l	NULL
-	NULL
i-	NULL
+-3	NULL
5	NULL
a	NULL
Pus	NULL
a	NULL
_	NULL
C	NULL
ca	NULL
2	NULL
2	NULL
~	NULL
Z	NULL
20	NULL
zo	NULL
i	NULL
2	NULL
>	NULL
&	NULL
5	NULL
a	NULL
>	NULL
>	NULL
i	NULL
m	NULL
10	NULL
io	NULL
j	NULL
10	NULL
a	NULL
5	NULL
10	NULL
s	NULL
a	NULL
&	NULL
CC	NULL
CC	NULL
0	NULL
0	NULL
PIP	NULL
P/P	NULL
H7	NULL
PIP	NULL
P/P	NULL
H7	NULL
PIP	NULL
O-	NULL
P/P	NULL
HZ	NULL
P/P	NULL
-	NULL
P/P	NULL
H7	NULL
P/P	NULL
P/P	NULL
H7	NULL
P/P	NULL
-	NULL
P/P	NULL
H7	NULL
H7	NULL
H7	NULL
H7	NULL
H7	NULL
H7	NULL
H7	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
H-7	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
shows	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
USF	NULL
,	NULL
NF-xB	NULL
,	NULL
and	NULL
AP-1	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
22F6	NULL
is	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
133	NULL
is	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cell	NULL
line	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
(	NULL
P/P	NULL
)	NULL
or	NULL
sterile	NULL
water	NULL
(	NULL
-	NULL
)	NULL
.	NULL

H-7	NULL
was	NULL
added	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
incubation	NULL
.	NULL

Retarded	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
shown	NULL
;	NULL
free	NULL
DNA	NULL
complexes	NULL
are	NULL
not	NULL
shown	NULL
but	NULL
were	NULL
equivalent	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
evaluated	NULL
by	NULL
laser	NULL
densitometry	NULL
.	NULL

with	NULL
TNF	NULL
or	NULL
IL-1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
paralleled	NULL
those	NULL
obtained	NULL
with	NULL
HIV-1-CAT	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Nef	NULL
protein	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
the	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
of	NULL
T-cell	NULL
activation	NULL
originating	NULL
from	NULL
the	NULL
TNF	NULL
or	NULL
IL-1	NULL
receptors	NULL
.	NULL

To	NULL
further	NULL
evaluate	NULL
the	NULL
effects	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
signal	NULL
transduction	NULL
after	NULL
PMA	NULL
or	NULL
PHA	NULL
stimulation	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
addition	NULL
of	NULL
a	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
,	NULL
H-7	NULL
,	NULL
was	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
noninducible	NULL
factor	NULL
USF	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

PMA	NULL
or	NULL
PHA	NULL
induction	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
was	NULL
10-fold	NULL
higher	NULL
in	NULL
the	NULL
22F6	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
.	NULL

The	NULL
use	NULL
of	NULL
H-7	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
the	NULL
cells	NULL
that	NULL
did	NULL
not	NULL
express	NULL
Nef	NULL
protein	NULL
.	NULL

Similarly	NULL
,	NULL
PMA	NULL
and	NULL
PHA	NULL
resulted	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
to	NULL
a	NULL
level	NULL
that	NULL
was	NULL
15	NULL
times	NULL
higher	NULL
in	NULL
the	NULL
cells	NULL
not	NULL
expressing	NULL
Nef	NULL
protein	NULL
than	NULL
in	NULL
the	NULL
cells	NULL
expressing	NULL
Nef	NULL
protein	NULL
.	NULL

H-7	NULL
blocked	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
in	NULL
the	NULL
22F6	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
H-7	NULL
to	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cells	NULL
did	NULL
not	NULL
cause	NULL
any	NULL
further	NULL
decrease	NULL
in	NULL
the	NULL
already	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
respective	NULL
transcription	NULL
factors	NULL
.	NULL

To	NULL
further	NULL
establish	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
Nef	NULL
protein	NULL
were	NULL
related	NULL
to	NULL
stimulation	NULL
through	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
,	NULL
both	NULL
Jurkat	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
anti-CD3	NULL
cross-linking	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
H-7	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Noninducible	NULL
transcription	NULL
factor	NULL
USF	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
in	NULL
22F6	NULL
cells	NULL
was	NULL
increased	NULL
fivefold	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
antibodies	NULL
to	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
H-7	NULL
attenuated	NULL
the	NULL
induction	NULL
to	NULL
a	NULL
level	NULL
comparable	NULL
to	NULL
that	NULL
achieved	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
.	NULL

Again	NULL
,	NULL
induction	NULL
was	NULL
not	NULL
further	NULL
decreased	NULL
by	NULL
H-7	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
,	NULL
because	NULL
levels	NULL
were	NULL
already	NULL
fivefold	NULL
lower	NULL
for	NULL
the	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
than	NULL
for	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
oligonucleotide	NULL
for	NULL
AP-1	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
,	NULL
with	NULL
differences	NULL
of	NULL
eightfold	NULL
for	NULL
the	NULL
anti-CD3	NULL
antibody	NULL
stimulation	NULL
of	NULL
22F6	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
133	NULL
cells	NULL
.	NULL

To	NULL
corroborate	NULL
that	NULL
the	NULL
effects	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
were	NULL
correlated	NULL
with	NULL
transcriptional	NULL
activity	NULL
,	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
acetylation	NULL
was	NULL
decreased	NULL
by	NULL
sixfold	NULL
with	NULL
the	NULL
use	NULL
of	NULL
H-7	NULL
in	NULL
22F6	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
for	NULL
HIV-1-CAT	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
percentage	NULL
of	NULL
acetylation	NULL
in	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
H-7	NULL
was	NULL
5.5-fold	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
.	NULL

The	NULL
results	NULL
with	NULL
the	NULL
IL-2-CAT	NULL
plasmid	NULL
with	NULL
both	NULL
22F6	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
and	NULL
133	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
celis	NULL
again	NULL
paralleled	NULL
those	NULL
of	NULL
the	NULL
HIV-1-CAT	NULL
plasmid	NULL
,	NULL
except	NULL
for	NULL
the	NULL
greater	NULL
differences	NULL
found	NULL
between	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cells	NULL
and	NULL
the	NULL
parental	NULL
cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
findings	NULL
with	NULL
IL-2-CAT	NULL
reflect	NULL
previously	NULL
described	NULL
Nef	NULL
protein	NULL
effects	NULL
on	NULL
endogenous	NULL
IL-2	NULL
expression	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
above	NULL
indicate	NULL
that	NULL
Nef	NULL
protein	NULL
down-regulates	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
by	NULL
interacting	NULL
with	NULL
one	NULL
of	NULL
the	NULL
steps	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
from	NULL
the	NULL
TCR-CD3-CD4	NULL
complex	NULL
.	NULL

DISCUSSION	NULL
The	NULL
function	NULL
of	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
remains	NULL
unclear	NULL
.	NULL

Whether	NULL
the	NULL
results	NULL
of	NULL
the	NULL
experiments	NULL
in	NULL
vitro	NULL
correlate	NULL
with	NULL
an	NULL
in	NULL
vivo	NULL
situation	NULL
is	NULL
,	NULL
at	NULL
this	NULL
point	NULL
,	NULL
impossible	NULL
to	NULL
ascertain	NULL
.	NULL

The	NULL
only	NULL
available	NULL
animal	NULL
data	NULL
from	NULL
the	NULL
experiments	NULL
with	NULL
simian	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
B	NULL
)	NULL
NFKB	NULL
&	NULL
_3	NULL
&	NULL
RELATIVE	NULL
INTENSITY	NULL
RELATIVE	NULL
INTENSITY	NULL
i	NULL
cbs	NULL
-	NULL
cp3	NULL
cps	NULL
-	NULL
cbs	NULL
w	NULL
?	NULL

w	NULL
CD3	NULL
CDJ	NULL
cP	NULL
1	NULL
-	NULL
CD3	NULL
CD3	NULL
cP	NULL
H7	NULL
TCR-SPECIFIC	NULL
EFFECTS	NULL
OF	NULL
HIV-1	NULL
Nef	NULL
3247	NULL
CJAP-	NULL
CD3	NULL
CD3	NULL
133	NULL
RELATIVE	NULL
INTENSITY	NULL
CD3	NULL
CD3	NULL
cP	NULL
H7	NULL
CD3	NULL
CD3	NULL
cP	NULL
H7	NULL
-	NULL
CD3	NULL
CD3	NULL
cP	NULL
H7	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
cross-linked	NULL
antibody	NULL
to	NULL
CD3	NULL
(	NULL
CD3	NULL
)	NULL
or	NULL
soluble	NULL
CD3	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
immobilized	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
shows	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
USF	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
AP-1	NULL
.	NULL

H-7	NULL
was	NULL
added	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
incubation	NULL
.	NULL

cP	NULL
,	NULL
cold	NULL
probe	NULL
.	NULL

Retarded	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
shown	NULL
;	NULL
free	NULL
DNA	NULL
complexes	NULL
are	NULL
not	NULL
shown	NULL
but	NULL
were	NULL
equivalent	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
twice	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
evaluated	NULL
by	NULL
laser	NULL
densitometry	NULL
.	NULL

immunodeficiency	NULL
virus	NULL
may	NULL
indicate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
pathogenicity	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
6	NULL
,	NULL
22	NULL
)	NULL
in	NULL
vivo	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
results	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
experiments	NULL
among	NULL
various	NULL
groups	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
different	NULL
nef	NULL
alleles	NULL
(	NULL
18	NULL
,	NULL
43	NULL
,	NULL
48	NULL
)	NULL
,	NULL
the	NULL
conditions	NULL
of	NULL
the	NULL
experiment	NULL
(	NULL
23	NULL
)	NULL
,	NULL
or	NULL
the	NULL
use	NULL
of	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
7	NULL
)	NULL
versus	NULL
stable	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
our	NULL
in	NULL
vitro	NULL
system	NULL
,	NULL
Nef	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down-regulate	NULL
A	NULL
)	NULL
22F6	NULL
20	NULL
w	NULL
#	NULL
<	NULL
wi	NULL
C	NULL
2	NULL
co	NULL
o	NULL
al	NULL
0	NULL
rs	NULL
0	NULL
CTRL	NULL
CD3	NULL
CDVHT7	NULL
C	NULL
)	NULL
22F6	NULL
co	NULL
w	NULL
#	NULL
<	NULL
wi	NULL
40	NULL
CC	NULL
9	NULL
€	NULL
a	NULL
20	NULL
2	NULL
0	NULL
CTRL	NULL
CD3	NULL
CDVHT7	NULL
both	NULL
NF-kB	NULL
(	NULL
30	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
31	NULL
)	NULL
after	NULL
PMA	NULL
and	NULL
PHA	NULL
stimulation	NULL
.	NULL

The	NULL
current	NULL
work	NULL
aimed	NULL
at	NULL
clarifying	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
Nef	NULL
protein	NULL
by	NULL
examining	NULL
the	NULL
pathways	NULL
of	NULL
signal	NULL
transduction	NULL
affected	NULL
by	NULL
this	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Several	NULL
signalling	NULL
pathways	NULL
have	NULL
been	NULL
described	NULL
,	NULL
although	NULL
further	NULL
clarification	NULL
is	NULL
still	NULL
required	NULL
.	NULL

Multiple	NULL
stimuli	NULL
,	NULL
including	NULL
IL-1	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
38	NULL
)	NULL
,	NULL
133	NULL
20	NULL
um	NULL
4	NULL
<	NULL
Inj	NULL
5	NULL
E	NULL
10	NULL
o	NULL
-J	NULL
0	NULL
t.	NULL
CTRL	NULL
CD3	NULL
CDI/HT7	NULL
D	NULL
)	NULL
60	NULL
133	NULL
Ld	NULL
th	NULL
=	NULL
ao	NULL
<	NULL
mj	NULL
tC	NULL
6	NULL
<	NULL
9	NULL
»	NULL
O	NULL
tz	NULL
CTRL	NULL
CD3	NULL
CDVHT	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

CAT	NULL
assay	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
HIV	NULL
and	NULL
IL-2	NULL
transcription	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
22F6	NULL
[	NULL
A	NULL
]	NULL
is	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
133	NULL
[	NULL
B	NULL
]	NULL
is	NULL
the	NULL
Nef	NULL
protein-expressing	NULL
cell	NULL
line	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
HIV-1-long	NULL
terminal	NULL
repeat-CAT	NULL
and	NULL
stimulated	NULL
with	NULL
cross-linked	NULL
antibody	NULL
to	NULL
CD3	NULL
(	NULL
CD3	NULL
)	NULL
or	NULL
soluble	NULL
CD3	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
immobilized	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
CTRL	NULL
)	NULL
.	NULL

H-7	NULL
was	NULL
added	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
incubation	NULL
.	NULL

Similar	NULL
experiments	NULL
with	NULL
IL-2-CAT	NULL
were	NULL
performed	NULL
with	NULL
22F6	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
and	NULL
133	NULL
cells	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
four	NULL
times	NULL
with	NULL
each	NULL
plasmid	NULL
,	NULL
a	NULL
mean	NULL
fold	NULL
induction	NULL
was	NULL
calculated	NULL
,	NULL
and	NULL
the	NULL
standard	NULL
deviation	NULL
of	NULL
the	NULL
mean	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
acetylation	NULL
for	NULL
HIV-1-CAT	NULL
were	NULL
0.3	NULL
+	NULL
0.02	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
4.1	NULL
+	NULL
0.45	NULL
(	NULL
CD3	NULL
)	NULL
,	NULL
and	NULL
0.75	NULL
+	NULL
0.2	NULL
(	NULL
CD3/H7	NULL
)	NULL
for	NULL
22F6	NULL
cells	NULL
and	NULL
0.3	NULL
+	NULL
0.06	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
0.7	NULL
+	NULL
0.1	NULL
(	NULL
CD3	NULL
)	NULL
,	NULL
and	NULL
0.4	NULL
+	NULL
0.06	NULL
(	NULL
CD3/H7	NULL
)	NULL
for	NULL
133	NULL
cells	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
acetylation	NULL
for	NULL
IL-2-CAT	NULL
were	NULL
0.2	NULL
+	NULL
0.03	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
16.2	NULL
+	NULL
0.8	NULL
(	NULL
CD3	NULL
)	NULL
,	NULL
and	NULL
1.5	NULL
+	NULL
0.25	NULL
(	NULL
CD3/H7	NULL
)	NULL
for	NULL
22F6	NULL
cells	NULL
and	NULL
0.4	NULL
+	NULL
0.04	NULL
(	NULL
CTRL	NULL
)	NULL
,	NULL
2.1	NULL
+	NULL
0.35	NULL
(	NULL
CD3	NULL
)	NULL
,	NULL
and	NULL
0.9	NULL
+	NULL
0.25	NULL
for	NULL
133	NULL
cells	NULL
.	NULL

3248	NULL
BANDRES	NULL
AND	NULL
RATNER	NULL
CD28	NULL
(	NULL
46	NULL
)	NULL
,	NULL
CD45	NULL
(	NULL
24	NULL
)	NULL
,	NULL
TNF	NULL
(	NULL
25	NULL
,	NULL
38	NULL
,	NULL
39	NULL
,	NULL
47	NULL
)	NULL
,	NULL
gamma	NULL
interferon	NULL
(	NULL
47	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
4	NULL
)	NULL
,	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
4	NULL
,	NULL
25	NULL
,	NULL
38	NULL
)	NULL
,	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
Tax	NULL
protein	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
the	NULL
antigenic	NULL
stimulation	NULL
of	NULL
the	NULL
TCR-CD3-CD4	NULL
complex	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
IL-2	NULL
and	NULL
IL-8	NULL
and	NULL
surrogate	NULL
HIV	NULL
genes	NULL
.	NULL

The	NULL
diverse	NULL
mechanisms	NULL
by	NULL
which	NULL
this	NULL
stimulation	NULL
is	NULL
achieved	NULL
include	NULL
direct	NULL
stimulation	NULL
of	NULL
the	NULL
hydrolysis	NULL
of	NULL
inositol	NULL
phospholipids	NULL
by	NULL
CD45	NULL
(	NULL
24	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
as	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
)	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
I-	NULL
«	NULL
kB	NULL
through	NULL
breakdown	NULL
of	NULL
sphingomyelin	NULL
products	NULL
to	NULL
ceramide	NULL
(	NULL
as	NULL
with	NULL
TNF	NULL
)	NULL
(	NULL
2	NULL
,	NULL
27	NULL
,	NULL
37	NULL
,	NULL
42	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
current	NULL
work	NULL
indicates	NULL
that	NULL
Nef	NULL
protein	NULL
affects	NULL
the	NULL
T-cell	NULL
signal	NULL
transduction	NULL
pathway	NULL
originating	NULL
from	NULL
TCR-CD3	NULL
complex	NULL
stimulation	NULL
.	NULL

Nef	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down-regulate	NULL
CD4	NULL
,	NULL
but	NULL
it	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
CD3	NULL
(	NULL
12	NULL
)	NULL
or	NULL
TCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Therefore	NULL
,	NULL
Nef	NULL
protein	NULL
probably	NULL
affects	NULL
one	NULL
of	NULL
the	NULL
downstream	NULL
steps	NULL
resulting	NULL
from	NULL
stimulation	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

Whether	NULL
this	NULL
is	NULL
due	NULL
to	NULL
physical	NULL
interaction	NULL
with	NULL
a	NULL
component	NULL
or	NULL
components	NULL
of	NULL
this	NULL
pathway	NULL
,	NULL
like	NULL
the	NULL
£	NULL
subunit	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
or	NULL
whether	NULL
it	NULL
is	NULL
due	NULL
to	NULL
enzymatic	NULL
regulation	NULL
of	NULL
pathway	NULL
intermediates	NULL
like	NULL
tyrosine	NULL
kinases	NULL
(	NULL
Ick	NULL
)	NULL
or	NULL
tyrosine	NULL
phosphatases	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
Nef	NULL
protein	NULL
on	NULL
CD4	NULL
expression	NULL
requires	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
(	NULL
12	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
two	NULL
sites	NULL
that	NULL
bind	NULL
to	NULL
p56**	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Whether	NULL
Nef	NULL
affects	NULL
CD4	NULL
expression	NULL
and	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
same	NULL
molecular	NULL
interaction	NULL
or	NULL
through	NULL
a	NULL
different	NULL
mechanism	NULL
needs	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
effects	NULL
in	NULL
vitro	NULL
on	NULL
transcriptional	NULL
regulation	NULL
correlate	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
effects	NULL
of	NULL
Nef	NULL
protein	NULL
requires	NULL
first	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
its	NULL
action	NULL
in	NULL
vitro	NULL
.	NULL

It	NULL
needs	NULL
to	NULL
be	NULL
kept	NULL
in	NULL
mind	NULL
that	NULL
our	NULL
in	NULL
vitro	NULL
system	NULL
does	NULL
not	NULL
take	NULL
into	NULL
account	NULL
circumstances	NULL
that	NULL
could	NULL
be	NULL
important	NULL
in	NULL
an	NULL
in	NULL
vivo	NULL
situation	NULL
and	NULL
could	NULL
be	NULL
affected	NULL
by	NULL
Nef	NULL
protein	NULL
,	NULL
such	NULL
as	NULL
reinfection	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
are	NULL
unable	NULL
to	NULL
ascertain	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
diverse	NULL
activities	NULL
of	NULL
Nef	NULL
protein	NULL
.	NULL

This	NULL
report	NULL
indicates	NULL
that	NULL
Nef	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
originating	NULL
from	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
and	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
cytokines	NULL
IL-1	NULL
and	NULL
TNF	NULL
.	NULL

The	NULL
complete	NULL
definition	NULL
of	NULL
this	NULL
system	NULL
is	NULL
required	NULL
to	NULL
determine	NULL
if	NULL
Nef	NULL
protein	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
cellular	NULL
latency	NULL
of	NULL
HIV	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
through	NULL
which	NULL
mechanism	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Lisa	NULL
Westfield	NULL
and	NULL
Evan	NULL
Sadler	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
,	NULL
William	NULL
R.	NULL
Hastings	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Sylvie	NULL
Luria	NULL
for	NULL
providing	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
U.S.	NULL
Army	NULL
grant	NULL
DAMD-17-90C-0125	NULL
to	NULL
LR	NULL
.	NULL

and	NULL
ACS	NULL
grant	NULL
FRA373	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
G.	NULL
Chan	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1985	NULL
.	NULL

Trans-activator	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III	NULL
)	NULL
.	NULL

Science	NULL
229:69-73	NULL
.	NULL

2	NULL
.	NULL

Atluru	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Polam	NULL
,	NULL
S.	NULL
Atluru	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Woloschak	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
mitogen-stimulated	NULL
human	NULL
T-cell	NULL
proliferation	NULL
,	NULL
IL-2	NULL
production	NULL
and	NULL
IL-2	NULL
receptor	NULL
expression	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
H7	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

129:310-320	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

4	NULL
.	NULL

Bomsztyk	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
T.	NULL
Iwaski	NULL
,	NULL
N.	NULL
A.	NULL
Rachie	NULL
,	NULL
S.	NULL
K.	NULL
Dower	NULL
,	NULL
and	NULL
C.	NULL
Hopkins	NULL
Sibley	NULL
.	NULL

1991	NULL
.	NULL

Evidence	NULL
that	NULL
interleukin-1	NULL
and	NULL
phorbol	NULL
esters	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
different	NULL
pathways	NULL
:	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Cell	NULL
Regul	NULL
.	NULL

2:329-335	NULL
.	NULL

5	NULL
.	NULL

Crise	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Rose	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
palmitoylation	NULL
sites	NULL
on	NULL
CD4	NULL
,	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:13593-13597	NULL
.	NULL

6	NULL
.	NULL

Daniel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
F.	NULL
Kirchhoff	NULL
,	NULL
S.	NULL
C.	NULL
Czajak	NULL
,	NULL
P.	NULL
K.	NULL
Seghal	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1992	NULL
.	NULL

Protective	NULL
effects	NULL
of	NULL
a	NULL
live	NULL
attenuated	NULL
SIV	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

vaccine	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

Science	NULL
258:1938-1941.	NULL
.	NULL

deRonde	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Klaver	NULL
,	NULL
W.	NULL
Keulen	NULL
,	NULL
L.	NULL
Smit	NULL
,	NULL
and	NULL
J.	NULL
Goudsmit	NULL
.	NULL

1992	NULL
.	NULL

Natural	NULL
HIV	NULL
nef	NULL
accelerates	NULL
virus	NULL
replication	NULL
in	NULL
primary	NULL
human	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
188:391-395.	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
M.	NULL
N.	NULL
Municio	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
V.	NULL
Diaz-Golpe	NULL
,	NULL
M.	NULL
T.	NULL
Lain	NULL
de	NULL
Lera	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
blocks	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
;	NULL
4770-4775.	NULL
.	NULL

Edbrooke	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
Foldi	NULL
,	NULL
J.	NULL
K.	NULL
Cheshire	NULL
,	NULL
F.	NULL
Li	NULL
,	NULL
D.	NULL
J.	NULL
Faulkes	NULL
,	NULL
and	NULL
P.	NULL
Woo	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
and	NULL
NF-B-like	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
serum	NULL
amyloid	NULL
a	NULL
gene	NULL
by	NULL
interleukin	NULL
1	NULL
.	NULL

Cytokine	NULL
3:380-388	NULL
.	NULL

Fisher	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
L.	NULL
Ratner	NULL
,	NULL
H.	NULL
Mitsuya	NULL
,	NULL
L.	NULL
M.	NULL
Marselle	NULL
,	NULL
M.	NULL
E.	NULL
Harper	NULL
,	NULL
S.	NULL
Broder	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1986	NULL
.	NULL

Infectious	NULL
mutants	NULL
of	NULL
HTLV-III	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
3	NULL
'	NULL
region	NULL
and	NULL
markedly	NULL
reduced	NULL
cytopathic	NULL
effects	NULL
.	NULL

Science	NULL
233:655-659	NULL
.	NULL

Franchini	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
J.	NULL
Ghrayeb	NULL
,	NULL
N.	NULL
T.	NULL
Chang	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1986	NULL
.	NULL

Cytoplasmic	NULL
localization	NULL
of	NULL
the	NULL
HTLV-III	NULL
3	NULL
'	NULL
orf	NULL
in	NULL
cultured	NULL
human	NULL
T-cells	NULL
.	NULL

Virology	NULL
155:593-599	NULL
.	NULL

Garcia	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
J.	NULL
Alfano	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Miller	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
negative	NULL
effect	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Nef	NULL
on	NULL
cell	NULL
surface	NULL
expression	NULL
is	NULL
not	NULL
species	NULL
specific	NULL
and	NULL
requires	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1511-1516	NULL
.	NULL

Garcia	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Miller	NULL
,	NULL
1991	NULL
.	NULL

Serine	NULL
phosphorylation-independent	NULL
down-regulation	NULL
of	NULL
cell	NULL
surface	NULL
CD4	NULL
by	NULL
nef	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:508-511	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-xB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
G.	NULL
T.	NULL
Merlino	NULL
,	NULL
M.	NULL
C.	NULL
Willingham	NULL
,	NULL
I.	NULL
Pastan	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

The	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
a	NULL
strong	NULL
promoter	NULL
when	NULL
introduced	NULL
into	NULL
a	NULL
variety	NULL
of	NULL
eukaryotic	NULL
cells	NULL
by	NULL
DNA-mediated	NULL
transfection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6777-6781	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
1991	NULL
.	NULL

The	NULL
molecular	NULL
biology	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324:308-317	NULL
.	NULL

Gur	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
C.	NULL
Wacholtz	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
T.	NULL
D.	NULL
Geppert	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1992	NULL
.	NULL

Modulatory	NULL
effect	NULL
of	NULL
aggregating	NULL
the	NULL
CD3	NULL
molecular	NULL
complex	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

140:81-96	NULL
.	NULL

Hammes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
M.	NULL
H.	NULL
Malim	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Nef	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
evidence	NULL
against	NULL
its	NULL
role	NULL
as	NULL
a	NULL
transcriptional	NULL
inhibitor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:9549-9553	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
Ix-B	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
:	NULL
182-185	NULL
.	NULL

Jamieson	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1991	NULL
.	NULL

Physio-logic	NULL
activation	NULL
of	NULL
T-cells	NULL
via	NULL
the	NULL
T-cell	NULL
receptor	NULL
induces	NULL
NF-KB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:416-420	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
M.	NULL
C.	NULL
Fletcher	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
L.	NULL
Schieven	NULL
,	NULL
J.	NULL
N.	NULL
Siegel	NULL
,	NULL
A.	NULL
F.	NULL
Phillips	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Sameison	NULL
.	NULL

1990	NULL
.	NULL

Inhibition	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
prevents	NULL
T-cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7722-7726	NULL
.	NULL

Kestler	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
D.	NULL
J.	NULL
Ringler	NULL
,	NULL
K.	NULL
Mori	NULL
,	NULL
D.	NULL
L.	NULL
Panicali	NULL
,	NULL
P.	NULL
K.	NULL
Seghal	NULL
,	NULL
M.	NULL
D.	NULL
Daniel	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1991	NULL
.	NULL

Importance	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
for	NULL
maintenance	NULL
of	NULL
high	NULL
virus	NULL
loads	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
AIDS	NULL
.	NULL

Cell	NULL
65:651-662	NULL
.	NULL

Kim	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Ikeuchi	NULL
,	NULL
R.	NULL
Byrn	NULL
,	NULL
J.	NULL
Groopman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Lack	NULL
of	NULL
a	NULL
negative	NULL
influence	NULL
on	NULL
viral	NULL
growth	NULL
by	NULL
the	NULL
nef	NULL
gene	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:9544-9548	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
M.	NULL
L.	NULL
Thomas	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
essential	NULL
for	NULL
coupling	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
phosphatidyl	NULL
inositol	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:66-68	NULL
.	NULL

Krasnow	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
L.	NULL
Osborn	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
interleukin-1	NULL
,	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
are	NULL
independent	NULL
activators	NULL
of	NULL
NF-kB	NULL
which	NULL
differentially	NULL
activate	NULL
T	NULL
cells	NULL
.	NULL

Cytokine	NULL
3:372-379	NULL
.	NULL

Luria	NULL
,	NULL
S.	NULL
,	NULL
I	NULL
.	NULL

Chambers	NULL
,	NULL
and	NULL
P.	NULL
Berg	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
type	NULL
1	NULL
immunodeficiency	NULL
virus	NULL
nef	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
prevents	NULL
antigen	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
receptor-mediated	NULL
induction	NULL
of	NULL
interleukin-2	NULL
mRNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5326-5330	NULL
.	NULL

Manger	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
J.	NULL
Imboden	NULL
,	NULL
T.	NULL
Laing	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
transmembrane	NULL
signaling	NULL
by	NULL
the	NULL
T-cell	NULL
receptor	NULL
antigen	NULL
complex	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:2755-2760	NULL
.	NULL

Mustelin	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
,	NULL
N.	NULL
Isakov	NULL
,	NULL
and	NULL
A.	NULL
Altman	NULL
.	NULL

1990	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
activation	NULL
of	NULL
phospholipase	NULL
C	NULL
requires	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Science	NULL
247:1584-1587	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T-cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
J.	NULL
V.	NULL
Garcia	NULL
,	NULL
W.	NULL
R.	NULL
Hastings	NULL
,	NULL
S.	NULL
Luria	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Nef	NULL
protein	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6213-6219	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
W.	NULL
R.	NULL
Hastings	NULL
,	NULL
S.	NULL
Luria	NULL
,	NULL
J.	NULL
C.	NULL
Bandres	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1993	NULL
.	NULL

HIV-1	NULL
Nef	NULL
protein	NULL
inhibits	NULL
the	NULL
recruitment	NULL
of	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
T-cells	NULL
.	NULL

Virology	NULL
194:338-344	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
W.	NULL
R.	NULL
Hastings	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1993	NULL
.	NULL

Myristoylation-enhanced	NULL
binding	NULL
of	NULL
the	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
to	NULL
T	NULL
cell	NULL
skeletal	NULL
matrix	NULL
.	NULL

Virology	NULL
197:420-425	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
W.	NULL
Hu	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Simian	NULL
immunodeficiency	NULL
virus	NULL
negative	NULL
factor	NULL
suppresses	NULL
the	NULL
level	NULL
of	NULL
viral	NULL
mRNA	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3538-3546	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
B.	NULL
J.	NULL
Thielan	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
negative	NULL
factor	NULL
is	NULL
a	NULL
transcriptional	NULL
silencer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1128-1132	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

LPS	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage	NULL
specific	NULL
stimulator	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:253-261	NULL
.	NULL

Rayter	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
M.	NULL
Woodrow	NULL
,	NULL
S.	NULL
C.	NULL
Lucas	NULL
,	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1992.	NULL
p21ras	NULL
mediates	NULL
control	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
function	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4549-4556	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Grassmann	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Antioxidants	NULL
selectively	NULL
suppress	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6288-6293	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

TCR-SPECIFIC	NULL
EFFECTS	NULL
OF	NULL
HIV-1	NULL
Nef	NULL
3249	NULL
Schutze	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Pothoff	NULL
,	NULL
T.	NULL
Machledt	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
K.	NULL
Wiegmann	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
activates	NULL
NF-kB	NULL
by	NULL
phosphatidylcho-line-specific	NULL
phospholipase	NULL
C-induced	NULL
``	NULL
acidic	NULL
``	NULL
sphingomyelin	NULL
breakdown	NULL
.	NULL

Cell	NULL
71:765-776	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
catalyzed	NULL
by	NULL
cyclic	NULL
AMP-depen-dent	NULL
protein	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2424-2430	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1986	NULL
.	NULL

Promoter	NULL
region	NULL
of	NULL
interleukin-2	NULL
gene	NULL
undergoes	NULL
chromatin	NULL
structure	NULL
changes	NULL
and	NULL
confers	NULL
inducibility	NULL
on	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3042-3049	NULL
.	NULL

Strahler	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
N.	NULL
Hailat	NULL
,	NULL
B.	NULL
Lamb	NULL
,	NULL
K.	NULL
P.	NULL
Rogers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Underhill	NULL
,	NULL
R.	NULL
F.	NULL
Melhem	NULL
,	NULL
D.	NULL
R.	NULL
Keins	NULL
,	NULL
X.	NULL
Zhu	NULL
,	NULL
R.	NULL
D.	NULL
Kuick	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Fox	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hanash	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
resting	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
through	NULL
the	NULL
T-cell	NULL
receptor	NULL
induces	NULL
rapid	NULL
phosphorylation	NULL
of	NULL
Op	NULL
18	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:1191-1198	NULL
.	NULL

Terwilliger	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1986	NULL
.	NULL

Effects	NULL
of	NULL
mutations	NULL
within	NULL
the	NULL
3	NULL
'	NULL
orf	NULL
open	NULL
reading	NULL
frame	NULL
region	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III/	NULL
LAV	NULL
)	NULL
on	NULL
replication	NULL
and	NULL
cytopathogenicity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

60:754-760.	NULL
.	NULL

Terwilliger	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
E.	NULL
Langhoff	NULL
,	NULL
D.	NULL
Gabuzda	NULL
,	NULL
E.	NULL
Zazopoulos	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1991	NULL
.	NULL

Allelic	NULL
variation	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
on	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:10971-10975	NULL
.	NULL

Valge	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
J.	NULL
G.	NULL
P.	NULL
Wong	NULL
,	NULL
D.	NULL
M.	NULL
Datlof	NULL
,	NULL
A.	NULL
J.	NULL
Sinskey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1988	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
is	NULL
required	NULL
for	NULL
responses	NULL
to	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
but	NULL
not	NULL
to	NULL
IL-2	NULL
in	NULL
T-cells	NULL
.	NULL

Cell	NULL
55:101-112	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
M.	NULL
Geerts	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Aarden	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:14179-14182	NULL
.	NULL

Yasumoto	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
S.	NULL
Murakai	NULL
,	NULL
M.	NULL
Mai	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interferon	NULL
gamma	NULL
synergistically	NULL
induce	NULL
interleukin	NULL
8	NULL
production	NULL
in	NULL
a	NULL
human	NULL
gastric	NULL
cancer	NULL
cell	NULL
line	NULL
through	NULL
acting	NULL
concurrently	NULL
on	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
interleukin	NULL
8	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22506-22511	NULL
.	NULL

Zazopoulos	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1992	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Eli	NULL
Nef	NULL
function	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
USA	NULL
89:6634-6638	NULL
.	NULL

